Drug Trial Radar · NCT07881887
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
617
Planned (sponsor's estimate)
Start
Oct 22, 2026
Primary completion
Mar 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight with or without Type 2 Diabetes. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last between approximately 53 to 89 weeks. For each participant (excluding those in Part B), the study will include between 5 and 7 stays in the Clinical Research Unit (CRU), each stay lasting between approximately 8 and 10 nights.
Conditions
- Obesity
- Overweight
- Diabetes Mellitus, Type 2
Interventions
LY4167586Drug
administered SC
PlaceboDrug
administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline through Study Completion (Estimated as Week 89)
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
Woodland Research Northwest, LLC
Rogers, Arkansas · Not yet recruiting
CenExel ACT
Anaheim, California · Recruiting
Collaborative Neuroscience Network - CNS
Los Alamitos, California · Recruiting
Diablo Clinical Research, Inc.
Walnut Creek, California · Recruiting
Fortrea Clinical Research Unit
Daytona Beach, Florida · Recruiting
Advanced Pharma CR, LLC
Miami, Florida · Not yet recruiting
Clinical Site Partners, LLC DBA CSP Orlando
Winter Park, Florida · Recruiting
Centricity Research
Columbus, Georgia · Recruiting
CenExel iResearch, LLC
Decatur, Georgia · Recruiting
QPS
Springfield, Missouri · Recruiting
CenExel-HRI
Marlton, New Jersey · Recruiting
Ohio Clinical Trials
Columbus, Ohio · Recruiting
Fortrea Clinical Research Unit
Dallas, Texas · Recruiting
Worldwide Clinical Trials, Inc.
San Antonio, Texas · Recruiting
Lilly Centre for Clinical Pharmacology
Singapore, Singapore · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.